EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The interplay mechanisms between gut microbiota and ferroptosis in inflammatory bowel disease

Zihan Shi, Shuyun Zhang, Hongru Zhai, Qingmin Wu, Yanyun Li, Huibin Xu, Shanlong Zhang

Frontiers in Immunology · 21.01.2026 · 17

DOI: 10.3389/fimmu.2026.1753617 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Immunology, online erschienen am 21.01.2026. Verfasst von Zihan Shi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, The Second Affiliated Hospital of Shandong First Medical University, Taian, Shandong, China. Hauptthemen laut MEDLINE: Ferroptosis, Inflammatory Bowel Diseases, Gastrointestinal Microbiome. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 240 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory bowel disease (IBD) is a chronic relapsing disorder driven by complex interactions between genetic susceptibility, immune dysregulation, and environmental factors. Ferroptosis has been identified as a key regulator in the progression of IBD. While much research focuses on endogenous signaling pathways, extrinsic mechanisms—particularly the modulation of IBD through the gut microbiota-induced ferroptosis remain underexplored. Dysregulated ferroptosis, influenced by gut microbiota, exacerbates microbial imbalance, creating a vicious cycle. Notably, the gut microbiota plays a critical role in IBD progression through multidimensional mechanisms, including regulation of metabolites, maintenance of immune homeostasis, and protection of the intestinal barrier. This review examines the microbiota–ferroptosis axis in IBD pathogenesis, aiming to provide insights into potential therapeutic strategies. In particular, we discuss emerging treatments targeting ferroptosis inhibition, iron homeostasis regulation, and microbiota interventions, which hold promise for improving clinical outcomes and promoting pathological recovery in IBD patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisInflammatory Bowel DiseasesGastrointestinal MicrobiomeHumansAnimalsIronHomeostasisIntestinal Barrier FunctionSignal Transduction

Stichwörter der Autor:innen

ferroptosisgut microbiotaironiron homeostasislipid peroxidation

Substanzen

Iron

Autor:innen und Institutionen

  • Department of Clinical Laboratory, The Second Affiliated Hospital of Shandong First Medical University, Taian, Shandong, China.

Zitieren

APA

Shi, Z., Zhang, S., Zhai, H., Wu, Q., Li, Y., Xu, H., & Zhang, S. (2026). The interplay mechanisms between gut microbiota and ferroptosis in inflammatory bowel disease. Frontiers in Immunology, 17. https://doi.org/10.3389/fimmu.2026.1753617

Vancouver

Shi Z, Zhang S, Zhai H, Wu Q, Li Y, Xu H, et al. The interplay mechanisms between gut microbiota and ferroptosis in inflammatory bowel disease. Frontiers in Immunology. 2026;17. doi:10.3389/fimmu.2026.1753617

BibTeX
@article{Shi2026,
  author = {Shi, Zihan and Zhang, Shuyun and Zhai, Hongru and Wu, Qingmin and Li, Yanyun and Xu, Huibin and Zhang, Shanlong},
  title = {The interplay mechanisms between gut microbiota and ferroptosis in inflammatory bowel disease},
  journal = {Frontiers in Immunology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fimmu.2026.1753617}
}
Kostenlos starten →